Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 1100029, India.
Zentrum für Infektiologie, Medizinische Mikrobiologie und Hygiene, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany.
Int J Mol Sci. 2019 Apr 29;20(9):2113. doi: 10.3390/ijms20092113.
Interleukin-9 (IL-9) is a pleiotropic cytokine and was primarily studied in the context of T helper 2 (T2)-associated immuno-pathological conditions such as asthma and parasitic infections. There was a paradigm shift in the biology of IL-9 after the recent discovery of T9 cells, a new subtype of T cells which secrete IL-9 in copious amounts. This has resulted in renewed interest in this cytokine, which was neglected since discovery because it was considered it to be just another T2 cytokine. Recent studies have shown that it has multiple cellular sources and is critically involved in the immune-pathogenesis of inflammatory diseases and in guarding immune tolerance. In this review, we will discuss its discovery, gene organization, cellular sources, and signaling pathways. Especially, we will give an update on the recent development regarding its relevance in the immune pathogenesis of human diseases.
白细胞介素-9 (IL-9) 是一种多效细胞因子,最初主要在 T 辅助 2 (T2) 相关免疫病理条件下进行研究,如哮喘和寄生虫感染。在最近发现 T9 细胞后,IL-9 的生物学发生了范式转变,T9 细胞是一种新型 T 细胞亚群,大量分泌 IL-9。这导致人们对这种细胞因子重新产生了兴趣,因为自发现以来,由于它被认为只是另一种 T2 细胞因子,所以一直被忽视。最近的研究表明,它有多种细胞来源,在炎症性疾病的免疫发病机制和免疫耐受保护中起着至关重要的作用。在这篇综述中,我们将讨论它的发现、基因组织、细胞来源和信号通路。特别是,我们将更新其在人类疾病免疫发病机制中的相关性的最新进展。